IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling

TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex

(2017) Chen Luo et al.   Oncotarget

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature

(2015) Elena I. Deryugina et al.   MATRIX BIOLOGY

Extracellular regulation of metalloproteinases

(2015) Kazuhiro Yamamoto et al.   MATRIX BIOLOGY

Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era

(2015) Josep M. Llovet et al.   Nature Reviews Clinical Oncology

BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages

(2015) Alessandra Rosati et al.   Nature Communications

Overexpression of IFITM3 predicts the high risk of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy

(2015) Yang Jia et al.   PeerJ

Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation

(2014) Da Huang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Ubiquitin-like Protein FAT10 Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Modifying  -Catenin Degradation

(2014) R. Yuan et al.   CANCER RESEARCH

Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer

(2014) JUN HU et al.   ONCOLOGY REPORTS

p38MAPK Plays a Crucial Role in Stromal-Mediated Tumorigenesis

(2014) E. Alspach et al.   Cancer Discovery

The role of IFITM3 in the growth and migration of human glioma cells

(2013) Bing Zhao et al.   BMC Neurology

Interferon-induced Transmembrane Protein 3 Is a Type II Transmembrane Protein

(2013) Charles C. Bailey et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle

(2013) MEI YANG et al.   ONCOLOGY REPORTS

KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis

(2011) D. Li et al.   CLINICAL CANCER RESEARCH

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL

Matrix Metalloproteinases

(2010) O. Zitka et al.   CURRENT MEDICINAL CHEMISTRY

Palmitoylome profiling reveals S-palmitoylation–dependent antiviral activity of IFITM3

(2010) Jacob S Yount et al.   Nature Chemical Biology

Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer

(2009) Roopali Roy et al.   JOURNAL OF CLINICAL ONCOLOGY

Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: A membrane proteomics approach

(2008) Nicholas T. Seyfried et al.   CANCER LETTERS